PLRZ (Polyrizon) ROCE %: -33.53% (As of Dec. 2025)


PLRZ Polyrizon Ltd PLRZ
14 GF Score
Price $12.61
! 4 Warning Signs
View Full Analysis

What is Polyrizon ROCE %?

Polyrizon PLRZ +1.28% 14 ROCE % is -33.53% as of Dec. 2025. GuruFocus rates PLRZ with a GF Score™ of 14/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Polyrizon's annualized ROCE % for the quarter that ended in Dec. 2025 was -33.53%.


Polyrizon  (NAS:PLRZ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Polyrizon ROCE % Related Terms


Polyrizon ROCE % Historical Data

* Premium members only.

The historical data trend for Polyrizon's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polyrizon ROCE % Chart

Polyrizon Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
0.00 0.00 -48.74 -44.03

Polyrizon Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial -1,087.72 -497.49 -69.35 -42.01 -33.53
PLRZ
14GF Score
Polyrizon Ltd PLRZ
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polyrizon ROCE % Calculation

Polyrizon's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-5.785/( ( (5.547 - 0.261) + (21.437 - 0.443) )/ 2 )
=-5.785/( (5.286+20.994)/ 2 )
=-5.785/13.14
=-44.03 %

Polyrizon's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-6.6/( ( (18.739 - 0.364) + (21.437 - 0.443) )/ 2 )
=-6.6/( ( 18.375 + 20.994 )/ 2 )
=-6.6/19.6845
=-33.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -33.53% mean?
Polyrizon (PLRZ) has a ROCE % of -33.53% as of Dec. 2025.
Is Polyrizon's ROCE % too high?
Polyrizon's current ROCE % is -33.53%. Overall, Polyrizon has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Polyrizon's ROCE % compare to SKYE and NEUP?
Polyrizon's ROCE % of -33.53% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Polyrizon's current ROCE % is -33.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polyrizon stock overvalued right now?
Polyrizon (PLRZ) has a current ROCE % of -33.53%. The current ROCE % is -33.53%. Polyrizon's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Polyrizon (PLRZ), the current ROCE % is -33.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polyrizon Business Description

Address 5 Ha-Tidhar Street, Raanana, ISR, 4366507
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
14GF Score

Get the complete analysis for PLRZ

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.61
Price